American Heart Journal

Papers
(The H4-Index of American Heart Journal is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Association of Increased Fructose Consumption with Atrial Fibrillation Symptoms229
Differences in Clinical Outcomes Between Non-Obese Caucasian and African American Populations Who Have Diabetes, A Nation-Wide Study199
Table of Contents125
Table of Contents94
Possibilities of Screening and Intervention Strategies in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus with the Risk of HF75
Editorial Board71
Arrhythmia Risk in Non-Obese versus Obese Patients with Psoriatic Arthritis and Type 2 Diabetes58
Impact of NT-proBNP Levels on Clinical Outcomes in Peripartum Cardiomyopathy: A Propensity-Matched Analysis Using the TriNetX Research Network57
Tirzepatide vs Semaglutide in Coronary Artery Disease and Obesity: Real-World Cardiovascular Outcomes Analysis from the TriNetX Research Network45
Information for Readers44
Accuracy of Diagnosing Diabetic Ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and DKA-HHS: The Significance for Cardiac Function42
Malignant left ventricular hypertrophy and risk of cognitive impairment in SPRINT MIND trial41
Operational challenges and mitigation measures during the COVID-19 pandemic–Lessons from DELIVER40
Information for Readers39
Heart failure and nocturnal hypoxemic burden, the connection is getting closer and closer37
COMPARE LAAO: Rationale and design of the randomized controlled trial “COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at hig36
Rationale and design of NUDGE-CKD: A nationwide randomized factorial trial of electronic nudges for increasing guideline-directed medical therapy in chronic kidney disease36
Nationwide Utilization of Danish Government Electronic letter system for increasing inFLUenza vaccine uptake (NUDGE-FLU): Study protocol for a nationwide randomized implementation trial35
Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: Study protocol for a multi-center, prospective, randomized, open-label, blinded e35
Physician responses to apple watch-detected irregular rhythm alerts34
Risk of delayed percutaneous coronary intervention for STEMI in the Southeast United States32
The rationale, design, and methods of a trial to evaluate the efficacy and safety of oxygen therapy in patients with intermediate-risk acute pulmonary embolism31
Diagnostic performance of a novel automated CT-derived FFR technology in detecting hemodynamically significant coronary artery stenoses: A multicenter trial in China31
Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings31
Absence of coronary artery disease in patients undergoing coronary imaging and association with amyloidosis: A Danish nationwide study31
Accuracy of instantaneous wave-free ratio and fractional flow reserve derived from single coronary angiographic projections31
Democracy, healthcare, and the public good30
Rationale and design of a pragmatic randomized clinical trial assessing a smartphone-based digital health intervention in hypertension: The ELFIE-HYPERTENSION trial30
Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial29
The trial to assess chelation therapy 2 (TACT2): Rationale and design29
0.080950021743774